科学研究
学术论文
当前位置: 首页>>科学研究>>学术论文>>正文

    王凯莉等Flavokawain A inhibits prostate cancer cells by inducing cell cycle arrest and cell apoptosis and regulating the glutamine metabolism Pathway

    2020-11-03   点击:[]

    Flavokawain A inhibits prostate cancer cells by inducing cell cycle

    arrest and cell apoptosis and regulating the glutamine metabolism

    Pathway

    【作者】Kaili Wang, Weijie Zhang, Zihan Wang, Ming Gao, Xinying Wang, Wenchao Han, Nan Zhang, Xia Xu

    【期刊名】Journal of Pharmaceutical and Biomedical Analysis

    【影响因子】 2019:3.209

    【作者单位】School of Pharmaceutical Sciences, Zhengzhou University, 100 Kexue Avenue, Zhengzhou 450001, PR China

    【年,卷:页码】2020, 186 : 113288

    【关键词】Flavokawain A, Prostate cancer, Cell cycle, Glutamine metabolism, Cell apoptosis, Metabolomics

    【摘要】Flavokawain A (FKA), a major chalcone in kava extracts, has exhibited anti-proliferative and apoptotic effects in the prostate cancer. However, the molecular mechanism of FKA remains unclear. In this study, FKA induces cell apoptosis and cell cycle arrest in a G2M phase to prostate cancer cells. FKA interferes with tubulin polymerization and inhibits survivin expression in PC3 cells. Molecular docking simulation experiment fifinds that FKA can bind to colchicine binding sites that inhibit tubulin polymerization. FKA treatment regulates the glutamine metabolism pathway in PC3 cells by reducing intracellular glutamine,

    glutamic and proline. FKA treatment also decreases the GSH content by decreasing the activity of GSH synthetase (GSS) and increasing the activity of glutathione thiol transferase (GSTP1), which subsequently

    induces ROS production and PC3 cell apoptosis.

    【全文链接】https://doi.org/10.1016/j.jpba.2020.113288


    上一条:于文艳等A specific “switch-on” type magnetic resonance nanoprobe with distance-dominate property for high-resolution imaging of tumors
    下一条:周园园等Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter

    关闭

版权所有:河南省靶向诊疗纳米药物重点实验室

地址:郑州市科学大道100号    邮编:450001